Want to join the conversation?
$EW's Transcatheter Heart Valve Therapy, or THVT, sales for 2Q16 jumped by 48.7% from last year, or 45.1% on underlying basis, driven by continued strong therapy adoption across all geographies, with notable strength in the U.S. In the U.S., THVT sales climbed 71.5% over last year, or 65.7% on an underlying basis.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?